Sabra Healthcare REIT (SBRA)
(Delayed Data from NSDQ)
$14.58 USD
+0.20 (1.39%)
Updated May 31, 2024 04:00 PM ET
After-Market: $14.60 +0.02 (0.14%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth D Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
SBRA 14.58 +0.20(1.39%)
Will SBRA be a Portfolio Killer in June?
Zacks Investment Research is releasing its prediction for SBRA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SBRA
Compared to Estimates, Sabra (SBRA) Q1 Earnings: A Look at Key Metrics
Exploring Analyst Estimates for Sabra (SBRA) Q1 Earnings, Beyond Revenue and EPS
SBRA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Sabra (SBRA) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Sabra Healthcare (SBRA) Lags Q4 FFO and Revenue Estimates
Ahead of Sabra (SBRA) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics
Other News for SBRA
What's Driving Medical Properties Trust Inc's Surprising 27% Stock Rally?
Picking A Winner In Healthcare REITs
Bag This Bargain 8.3% Yield Dividend Stock Even Cheaper Than Director Cusack Did
Sabra Health Care REIT Named Top Dividend Stock With Insider Buying and 8.32% Yield (SBRA)
Rally Gets Reality Check